Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation

201057 citationsJournal Article

Authors

Good health and well-being

Published in: Vaccine

Volume 29, Issue 4, pp. 795-803

Field-Weighted Citation Impact: 5.73